{"id":108784,"date":"2026-06-16T07:17:12","date_gmt":"2026-06-16T07:17:12","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/108784\/"},"modified":"2026-06-16T07:17:12","modified_gmt":"2026-06-16T07:17:12","slug":"novo-nordisk-to-seek-regulatory-approval-for-wegovy-pill-in-china-soon-says-ceo","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/108784\/","title":{"rendered":"Novo Nordisk to seek regulatory approval for Wegovy pill in China soon, says CEO"},"content":{"rendered":"<p><a data-ylk=\"elm:icon;slk:Reuters;\" href=\"https:\/\/www.reuters.com\/\" target=\"_blank\" rel=\"nofollow noopener\"><img alt=\"Reuters\" loading=\"lazy\" width=\"171\" height=\"40\" decoding=\"async\" data-nimg=\"1\" class=\"pr-2.5 max-w-[150px] max-h-[40px] min-[601px]:max-w-[115px]\" style=\"color:transparent;max-width:auto;max-height:100%\" src=\"https:\/\/www.europesays.com\/dk\/wp-content\/uploads\/2026\/06\/https:\/\/s.yimg.com\/os\/creatr-uploaded-images\/2020-11\/62e21440-2fbd-11eb-95ff-5673fa3d2f9f.jpeg\"\/><\/a>Tue, June 16, 2026 at 6:04 AM UTC<img alt=\"\" fetchpriority=\"high\" width=\"976\" height=\"606\" decoding=\"async\" data-nimg=\"1\" class=\"standard-img w-full w-full h-auto\" style=\"color:transparent\" src=\"https:\/\/www.europesays.com\/dk\/wp-content\/uploads\/2026\/06\/https:\/\/media.zenfs.com\/en\/reuters.com\/4f408e69b5abc287b392267dc97841b2.jpeg\"\/><\/p>\n<p>FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, December 3, 2025. REUTERS\/Tom Little\/File Photo<\/p>\n<p>BEIJING, June 16 (Reuters) &#8211; \u200cNovo Nordisk \u200cplans to \u200bseek Chinese regulatory approval for \u200cits \u2060weight-loss pill &#8220;very soon,&#8221; \u2060CEO Mike \u200bDoustdar \u200bsaid \u200bTuesday, in \u200ca move to catch up with \u200crival \u200bEli \u200bLilly \u200bin \u200cthe world&#8217;s second-largest \u200bpharmaceutical \u200bmarket.<\/p>\n<p>(Reporting by \u200bAndrew \u200cSilver; Editing \u200bby Christopher \u200bCushing)<\/p>\n","protected":false},"excerpt":{"rendered":"Tue, June 16, 2026 at 6:04 AM UTC FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is&hellip;\n","protected":false},"author":2,"featured_media":108785,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[272,10593,280],"class_list":["post-108784","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-novo-nordisk","tag-regulatory-approval","tag-weight-loss"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116758567244655824","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/108784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=108784"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/108784\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/108785"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=108784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=108784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=108784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}